Vertex Pharmaceuticals (VRTX) shares soared 5.3% in the last trading session to close at $461.68. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Journavx is the first new type of pain reliever approved by the FDA to hit the market in more than two decades. Emory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback